Your browser doesn't support javascript.
loading
Comprehensive mapping of the effects of azacitidine on DNA methylation, repressive/permissive histone marks and gene expression in primary cells from patients with MDS and MDS-related disease.
Tobiasson, Magnus; Abdulkadir, Hani; Lennartsson, Andreas; Katayama, Shintaro; Marabita, Francesco; De Paepe, Ayla; Karimi, Mohsen; Krjutskov, Kaarel; Einarsdottir, Elisabet; Grövdal, Michael; Jansson, Monika; Ben Azenkoud, Asmaa; Corddedu, Lina; Lehmann, Sören; Ekwall, Karl; Kere, Juha; Hellström-Lindberg, Eva; Ungerstedt, Johanna.
Afiliación
  • Tobiasson M; Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Division of Hematology Karolinska Institutet, Karolinska University Hospital Huddinge, Huddinge, Sweden.
  • Abdulkadir H; Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Division of Hematology Karolinska Institutet, Karolinska University Hospital Huddinge, Huddinge, Sweden.
  • Lennartsson A; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm County, Sweden.
  • Katayama S; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm County, Sweden.
  • Marabita F; Unit of Computational Medicine, Center for Molecular Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
  • De Paepe A; National Bioinformatics Infrastructure Sweden, Stockholm, Sweden.
  • Karimi M; Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Division of Hematology Karolinska Institutet, Karolinska University Hospital Huddinge, Huddinge, Sweden.
  • Krjutskov K; Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Division of Hematology Karolinska Institutet, Karolinska University Hospital Huddinge, Huddinge, Sweden.
  • Einarsdottir E; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm County, Sweden.
  • Grövdal M; Molecular Neurology Research Program, University of Helsinki, and Folkhälsan Institute of Genetics, Helsinki, Finland.
  • Jansson M; Competence Centre on Health Technologies, Tartu, Estonia.
  • Ben Azenkoud A; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm County, Sweden.
  • Corddedu L; Molecular Neurology Research Program, University of Helsinki, and Folkhälsan Institute of Genetics, Helsinki, Finland.
  • Lehmann S; Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Division of Hematology Karolinska Institutet, Karolinska University Hospital Huddinge, Huddinge, Sweden.
  • Ekwall K; Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Division of Hematology Karolinska Institutet, Karolinska University Hospital Huddinge, Huddinge, Sweden.
  • Kere J; Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Division of Hematology Karolinska Institutet, Karolinska University Hospital Huddinge, Huddinge, Sweden.
  • Hellström-Lindberg E; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm County, Sweden.
  • Ungerstedt J; Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Division of Hematology Karolinska Institutet, Karolinska University Hospital Huddinge, Huddinge, Sweden.
Oncotarget ; 8(17): 28812-28825, 2017 Apr 25.
Article en En | MEDLINE | ID: mdl-28427179

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Azacitidina / Síndromes Mielodisplásicos / Células de la Médula Ósea / Histonas / Retrovirus Endógenos / Antineoplásicos Límite: Humans Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Azacitidina / Síndromes Mielodisplásicos / Células de la Médula Ósea / Histonas / Retrovirus Endógenos / Antineoplásicos Límite: Humans Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Suecia